Dyskinesias and neural grafting in Parkinson's disease

Keyphrases

• Parkinson's Disease 100%
• Dyskinesia 100%
• Neural Graft 100%
• Mesencephalic 71%
• Intrastriatal 57%
• Transplantation 42%
• Striatum 28%
• Clinical Trials 28%
• Mesencephalic Tissue 28%
• Dopamine 28%
• Dopamine Neurons 14%
• Transplanted Patients 14%
• L-DOPA 14%
• Neural Transplantation 14%
• Dopamine Release 14%
• Cell Replacement 14%
• Treatment Strategy 14%
• Neurological Disorders 14%
• Graft-induced Dyskinesia 14%
• Cell Replacement Therapy 14%
• Treatment Options 14%
• Clinical Entities 14%
• Neuronal Cells 14%
• Intracerebral Transplantation 14%
• Transplantation Surgery 14%
• Possible Mechanisms 14%
• Further Application 14%
• Persistent Form 14%
• Levodopa-induced Dyskinesia 14%
• Nigrostriatal System 14%
• Parkinson's Disease Model 14%
• Severe Disease 14%
• Clinical Pathophysiology 14%
• Possible Treatments 14%
• Pharmacotherapy 14%
• Pathophysiological Models 14%
• Other-report 14%
• Endogeneity 14%
• Dunnett 14%
• Postoperative Period 14%
• Clinical Spectrum 14%
• Parkinsonian 14%
• Engraft 14%

Neuroscience

• Parkinson's Disease 100%
• Dyskinesia 100%
• Grafting 100%
• Striatum 22%
• L-DOPA 22%
• Treatment of Parkinson's Disease 22%
• Dopamine Release 11%
• Nervous System Cell 11%
• Neurological Disorder 11%